Published in Clinical Oncology Week, September 11th, 2006
Scientists in Greece report, "We studied the effect of levothyroxine (L-T4 ) suppressive therapy on bone mineral density (BMD) in pre-menopausal women with total thyroidectomy and radioactive iodine (131I) ablation therapy post-operatively for differentiated thyroid cancer (DTC)."
"We prospectively studied 26 athyroid pre-menopausal women (median age 39 years, range 28-48 years) receiving suppressive L-T4 therapy postoperatively for 48 months," wrote E.E. Mazokopakis and colleagues, University Hospital of Heraklion. "BMD was measured by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week